Clinical Trial Update: Gene and Protein Expression Profiles After Treatment of Actinic Keratoses [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating gene and protein expression profiles after treatment of actinic keratoses.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Snippet

Sponsor: Ismail Gögenur | Conditions: Actinic Keratoses | Phase 2 | Status: UNKNOWN